Oluwadunni Elebiju

Ms. Oluwadunni Elebiju


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
OEOluwadunni Elebiju
Oluwadunni Elebiju
Gbolahan Oladipupo OduseluGbolahan Oladipupo Oduselu
Gbolahan Oladipupo Oduselu
TOTemitope A. Ogunnupebi
Temitope A. Ogunnupebi
OAOlayinka O. Ajani
Olayinka O. Ajani
EAEzekiel Adebiyi
Ezekiel Adebiyi
The inhibition of O-acetyl sulphydrylase synthase isoforms has been reported to represent a promising approach for the development of antibiotic adjuvants. This occurs via the organism developing an unpaired oxidative stress response, causing a reduction in antibiotic resistance in vegetative and swarm cell populations. This consequently increases the effectiveness of conventional antibiotics at lower doses. This study aimed to predict potential inhibitors of Salmonella typhimurium ortho acetyl sulphydrylase synthase (StOASS), which has lower binding energy than the cocrystalized ligand pyridoxal 5 phosphate (PLP), using a computer-aided drug design approach including pharmacophore modeling, virtual screening, and in silico ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) evaluation. The screening and molecular docking of 4254 compounds obtained from the PubChem database were carried out using AutoDock vina, while a post-screening analysis was carried out using Discovery Studio. The best three hits were compounds with the PubChem IDs 118614633, 135715279, and 155773276, possessing binding affinities of −9.1, −8.9, and −8.8 kcal/mol, respectively. The in silico ADMET prediction showed that the pharmacokinetic properties of the best hits were relatively good. The optimization of the best three hits via scaffold hopping gave rise to 187 compounds, and they were docked against StOASS; this revealed that lead compound 1 had the lowest binding energy (−9.3 kcal/mol) and performed better than its parent compound 155773276. Lead compound 1, with the best binding affinity, has a hydroxyl group in its structure and a change in the core heterocycle of its parent compound to benzimidazole, and pyrimidine introduces a synergistic effect and consequently increases the binding energy. The stability of the best hit and optimized compound at the StOASS active site was determined using RMSD, RMSF, radius of gyration, and SASA plots generated from a molecular dynamics simulation. The MD simulation results were also used to monitor how the introduction of new functional groups of optimized compounds contributes to the stability of ligands at the target active site. The improved binding affinity of these compounds compared to PLP and their toxicity profile, which is predicted to be mild, highlights them as good inhibitors of StOASS, and hence, possible antimicrobial adjuvants.

1 May 2024 in IOP Conference Series: Earth and Environmental Science
Verified
Conference Paper
Open access
PDF file
TOT A Ogunnupebi
T A Ogunnupebi
Gbolahan Oladipupo OduseluGbolahan Oladipupo Oduselu
Gbolahan Oladipupo Oduselu
OEOluwadunni Elebiju
Oluwadunni Elebiju
OAO O Ajani
O O Ajani
EAEzekiel Adebiyi
Ezekiel Adebiyi
Antimicrobial resistance is becoming more rampant in our world today, and different measures are being taken to combat this challenge. Benzimidazoles are classified as heterocyclic compounds with notable pharmacological properties. As a result, benzimidazole has been combined with other compounds that have remarkable actions to create a more potent molecule. Exploring these substances to combat antibacterial resistance would therefore aid in achieving good health and wellbeing and promote sustainable development. Predicting the effectiveness of the compounds before manufacturing and clinical testing has made drug design easy. This study employs in silico methods like molecular docking to investigate alternate antibacterial agents from a library of benzimidazole derivatives. A library of compounds with a benzimidazole template was screened against the three-dimensional (3D) structure of peptidoglycan transpeptidase (PPB2A) of Staphylococcus aureus. Two binding sites were identified in the protein: the main site and the allosteric site. Molecular docking was done on the main and allosteric sites to obtain free binding energy ranging from -7.3 to -5.8 and -4.9 to -4.5 kcal/mol, respectively. The predictive Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) experiments were done on the compounds to ascertain their safety. The results were compared to those of known antibiotics, and the compounds performed effectively. The benzimidazole derivative can be adopted as a prospective antibacterial agent with an alternative pathway for combating resistance issues and enhancing the quality of health and well-being globally.